AVD - American Vanguard Co... Stock Analysis | Stock Taper
Logo
American Vanguard Corporation

AVD

American Vanguard Corporation NYSE
$2.64 1.15% (+0.03)

Market Cap $75.34 M
52w High $5.92
52w Low $2.05
Dividend Yield 1.36%
Frequency Quarterly
P/E -1.51
Volume 293.55K
Outstanding Shares 28.54M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2025 $150.69M $33.51M $-28.21M -18.72% $-0.97 $10.75M
Q3-2025 $119.31M $40.72M $-12.36M -10.36% $-0.43 $-3.04M
Q2-2025 $129.31M $36.18M $-849K -0.66% $-0.03 $8.73M
Q1-2025 $115.8M $34.5M $-8.46M -7.31% $-0.3 $200K
Q4-2024 $165.65M $92.87M $-90.43M -54.59% $-3.21 $-11.34M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2025 $12.43M $596.54M $404.14M $192.4M
Q3-2025 $16.8M $655.01M $434.02M $220.99M
Q2-2025 $14.48M $651.98M $421.16M $230.82M
Q1-2025 $11.8M $631.59M $404.23M $227.35M
Q4-2024 $12.51M $636.72M $403.61M $233.11M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q4-2025 $-104.67M $5.95M $-1.56M $-8.36M $-4.37M $4.43M
Q3-2025 $-12.36M $12.69M $-985K $-9.42M $2.31M $11.27M
Q2-2025 $-849K $-19.26M $-611K $21.68M $2.68M $-19.85M
Q1-2025 $-8.46M $-20.58M $-446K $19.8M $-709K $-21.03M
Q4-2024 $-90.43M $33.77M $-242K $-32.28M $634K $32.53M

Revenue by Products

Product Q3-2019Q4-2019Q1-2023Q4-2023
U S Crop
U S Crop
$0 $0 $60.00M $210.00M
U S Non Crop
U S Non Crop
$0 $0 $10.00M $60.00M
Amount Of Herbicides Sold
Amount Of Herbicides Sold
$50.00M $70.00M $0 $0
Amount Of Insecticides Sold
Amount Of Insecticides Sold
$40.00M $40.00M $0 $0
Crop
Crop
$0 $110.00M $0 $0
Non Crop Including Distribution Of Third Party Products
Non Crop Including Distribution Of Third Party Products
$20.00M $0 $0 $0
Other Including Plant Growth Regulators And Distribution
Other Including Plant Growth Regulators And Distribution
$20.00M $0 $0 $0

Revenue by Geography

Region Q1-2025Q2-2025Q3-2025Q4-2025
NonUS
NonUS
$40.00M $60.00M $60.00M $90.00M
UNITED STATES
UNITED STATES
$70.00M $70.00M $60.00M $100.00M

Q3 2025 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at American Vanguard Corporation's financial evolution and strategic trajectory over the past five years.

+ Strengths

American Vanguard combines a solid revenue base and acceptable gross margins with a long history of accumulated profits, as reflected in retained earnings. It holds strong competitive positions in targeted niche markets, backed by differentiated technologies such as SIMPAS, SmartCartridge, and a broad biologicals portfolio. Its regulatory expertise, integrated manufacturing footprint, and diversified end markets (including professional pest control and turf) add resilience. The company’s active R&D efforts and strategic focus on sustainable and precision agriculture give it exposure to attractive long-term growth themes.

! Risks

The largest concerns center on current financial performance and cash generation. Operations are presently unprofitable, and free cash flow is negative, even as the company continues to invest and return some cash to shareholders. A meaningful debt load and reliance on intangible assets increase sensitivity to prolonged weak results. The business is tied to cyclical agricultural conditions and subject to regulatory and environmental scrutiny, which can affect product portfolios. Execution risk also looms in areas like manufacturing consolidation, international expansion, and scaling new platforms; missteps could delay the intended benefits and further strain financial resources.

Outlook

Looking ahead, the company’s prospects hinge on its ability to turn innovation and niche strengths into improved profitability and stronger cash flow. If new products, precision-application systems, and biological solutions gain traction as expected, and if operational efficiency initiatives deliver, financial metrics could recover meaningfully over the next few years. At the same time, the current loss-making position and negative free cash flow warrant a cautious stance on the near term, as there is limited room for extended underperformance without further balance sheet adjustment. The overall picture is one of a strategically interesting business with tangible opportunities, but with execution and financial discipline as critical variables for the future trajectory.